149 related articles for article (PubMed ID: 18455887)
41. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.
Schütz CG; Rapiti E; Vlahov D; Anthony JC
Drug Alcohol Depend; 1994 Oct; 36(2):129-38. PubMed ID: 7851280
[TBL] [Abstract][Full Text] [Related]
42. Characteristics of heroin and cocaine users unknown to treatment agencies. Results from the Swiss Hidden Population Study.
Hausser D; Kübler D; Dubois-Arber F
Soz Praventivmed; 1999; 44(5):222-32. PubMed ID: 10588038
[TBL] [Abstract][Full Text] [Related]
43. Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors.
Lloyd-Smith E; Wood E; Li K; Montaner JS; Kerr T
Drug Alcohol Depend; 2009 Jan; 99(1-3):176-82. PubMed ID: 18805655
[TBL] [Abstract][Full Text] [Related]
44. HIV testing experience of drug users in Bali, Indonesia.
Sagung Sawitri AA; Sumantera GM; Wirawan DN; Ford K; Lehman E
AIDS Care; 2006 Aug; 18(6):577-88. PubMed ID: 16831786
[TBL] [Abstract][Full Text] [Related]
45. Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence.
Anderson AM; Higgins MK; Ownby RL; Waldrop-Valverde D
AIDS Care; 2015; 27(3):333-7. PubMed ID: 25484035
[TBL] [Abstract][Full Text] [Related]
46. Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection.
Kuo I; Sherman SG; Thomas DL; Strathdee SA
Drug Alcohol Depend; 2004 Jan; 73(1):69-78. PubMed ID: 14687961
[TBL] [Abstract][Full Text] [Related]
47. Brief motivational intervention at a clinic visit reduces cocaine and heroin use.
Bernstein J; Bernstein E; Tassiopoulos K; Heeren T; Levenson S; Hingson R
Drug Alcohol Depend; 2005 Jan; 77(1):49-59. PubMed ID: 15607841
[TBL] [Abstract][Full Text] [Related]
48. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.
Anthony JC; Vlahov D; Nelson KE; Cohn S; Astemborski J; Solomon L
Am J Epidemiol; 1991 Nov; 134(10):1175-89. PubMed ID: 1746528
[TBL] [Abstract][Full Text] [Related]
49. Remission from drug dependence symptoms and drug use cessation among women drug users in puerto rico.
Warner LA; Alegría M; Canino G
Arch Gen Psychiatry; 2004 Oct; 61(10):1034-41. PubMed ID: 15466677
[TBL] [Abstract][Full Text] [Related]
50. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China.
Garten RJ; Lai S; Zhang J; Liu W; Chen J; Vlahov D; Yu XF
Int J Epidemiol; 2004 Feb; 33(1):182-8. PubMed ID: 15075167
[TBL] [Abstract][Full Text] [Related]
51. Demographic and Clinical Features of Chinese Heroin Users Who Switch from Non-injection to Injection.
Cui S; Li Y; Xiang YT; Yan KJ; Fan C; Chen Q; Du W; Zhang G; Xiao L; Li Y; Yuan X; Xie K; Luo X
Subst Use Misuse; 2015; 50(14):1739-46. PubMed ID: 26683897
[TBL] [Abstract][Full Text] [Related]
52. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs).
Miller CL; Strathdee SA; Li K; Kerr T; Wood E
Am J Drug Alcohol Abuse; 2007; 33(4):527-36. PubMed ID: 17668338
[TBL] [Abstract][Full Text] [Related]
53. Roles and Functions of Social Networks Among Men Who Use Drugs in ART Initiation in Vietnam.
Latkin CA; Smith MK; Ha TV; Mo TT; Zelaya C; Sripaipan T; Le Minh N; Quan VM; Go VF
AIDS Behav; 2016 Nov; 20(11):2782-2789. PubMed ID: 27125243
[TBL] [Abstract][Full Text] [Related]
54. High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.
Vallejo F; Barrio G; Brugal MT; Pulido J; Toro C; Sordo L; Espelt A; Bravo MJ;
J Epidemiol Community Health; 2015 Jun; 69(6):599-603. PubMed ID: 25870164
[TBL] [Abstract][Full Text] [Related]
55. The relationship between performance on the Shipley Institute of Living Scale (SILS) and hepatitis C infection among active injection drug users in Baltimore, Maryland.
Severtson SG; Mitchell MM; Hubert A; Latimer W
Am J Drug Alcohol Abuse; 2010 Jan; 36(1):61-5. PubMed ID: 20141399
[TBL] [Abstract][Full Text] [Related]
56. Polydrug use and implications for longitudinal research: ten-year trajectories for heroin, cocaine, and methamphetamine users.
Brecht ML; Huang D; Evans E; Hser YI
Drug Alcohol Depend; 2008 Aug; 96(3):193-201. PubMed ID: 18329825
[TBL] [Abstract][Full Text] [Related]
57. Differences in impulsivity and risk-taking propensity between primary users of crack cocaine and primary users of heroin in a residential substance-use program.
Bornovalova MA; Daughters SB; Hernandez GD; Richards JB; Lejuez CW
Exp Clin Psychopharmacol; 2005 Nov; 13(4):311-8. PubMed ID: 16366761
[TBL] [Abstract][Full Text] [Related]
58. The effect of entering drug treatment on involvement in HIV-related risk behaviors.
Hoffman JA; Klein H; Clark DC; Boyd FT
Am J Drug Alcohol Abuse; 1998 May; 24(2):259-84. PubMed ID: 9643465
[TBL] [Abstract][Full Text] [Related]
59. Poly-drug and marijuana use among adults who primarily used methamphetamine.
Herbeck DM; Brecht ML; Lovinger K; Raihan A; Christou D; Sheaff P
J Psychoactive Drugs; 2013; 45(2):132-40. PubMed ID: 23909001
[TBL] [Abstract][Full Text] [Related]
60. Factors predicting entry of injecting drug users into substance abuse treatment.
Zule WA; Desmond DP
Am J Drug Alcohol Abuse; 2000 May; 26(2):247-61. PubMed ID: 10852359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
